CCMH
GHDX

Cornerstone Capital Management Holdings’s Genomic Health, Inc. GHDX Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$937K Buy
27,437
+11,100
+68% +$354K 0.01% 910
2017
Q3 		$524K Buy
16,337
+3,000
+22% +$94.6K ﹤0.01% 1050
2017
Q2 		$433K Sell
13,337
-8,217
-38% -$260K ﹤0.01% 1055
2017
Q1 		$678K Sell
21,554
-57,350
-73% -$1.7M 0.01% 998
2016
Q4 		$2.32M Sell
78,904
-60,457
-43% -$1.84M 0.02% 702
2016
Q3 		$4.03M Buy
139,361
+7,400
+6% +$206K 0.03% 535
2016
Q2 		$3.42M Buy
131,961
+74,500
+130% +$1.98M 0.03% 559
2016
Q1 		$1.42M Buy
57,461
+40,700
+243% +$1.12M 0.01% 832
2015
Q4 		$590K Buy
16,761
+7,461
+80% +$200K ﹤0.01% 1002
2015
Q3 		$197K Sell
9,300
-65,700
-88% -$1.69M ﹤0.01% 1221
2015
Q2 		$2.08M Buy
75,000
+10,000
+15% +$282K 0.02% 703
2015
Q1 		$1.99M Sell
65,000
-5,900
-8% -$188K 0.02% 724
2014
Q4 		$2.27M Buy
70,900
+56,400
+389% +$1.84M 0.02% 670
2014
Q3 		$410K Buy
14,500
+9,600
+196% +$268K ﹤0.01% 1003
2014
Q2 		$134K Sell
4,900
-5,300
-52% -$141K ﹤0.01% 1157
2014
Q1 		$269K Sell
10,200
-16,554
-62% -$475K ﹤0.01% 1074
2013
Q4 		$783K Sell
26,754
-12,346
-32% -$392K 0.01% 862
2013
Q3 		$1.2M Buy
+39,100
New +$1.31M 0.01% 779

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Cornerstone Capital Management Holdings's GHDX Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Genomic Health, Inc. (GHDX) stake by 68% in Q4 2017, buying an estimated $354K and bringing the position to 27,437 shares worth $937K. The position accounts for 0.01% of the portfolio, ranked #910.

Cornerstone Capital Management Holdings first reported a position in GHDX in Q3 2013 and has held it in 18 quarters since. The position peaked at $4.03M in Q3 2016. 135 funds tracked by Wall St. Rank hold GHDX as of Q4 2017.

  • Cornerstone Capital Management Holdings held 27,437 shares of Genomic Health, Inc. worth $937K as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 11,100 Genomic Health, Inc. shares in Q4 2017, an estimated $354K.
  • Genomic Health, Inc. made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #910 holding.
  • Cornerstone Capital Management Holdings first reported a position in Genomic Health, Inc. in Q3 2013 and has held it in 18 quarters since.
  • Cornerstone Capital Management Holdings's Genomic Health, Inc. position peaked at $4.03M in Q3 2016.
  • 135 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.